Table: begin end state 1 23 cytoplasmic 24 42 transmembrane 43 55 non-cytoplasmic 56 75 transmembrane 76 88 cytoplasmic 89 108 transmembrane 109 113 non-cytoplasmic 114 136 transmembrane 137 147 cytoplasmic 148 171 transmembrane 172 181 non-cytoplasmic 182 203 transmembrane 204 250 cytoplasmic 251 272 transmembrane 273 288 non-cytoplasmic 289 309 transmembrane 310 316 cytoplasmic 317 333 transmembrane 334 338 non-cytoplasmic 339 360 transmembrane 361 370 cytoplasmic 371 394 transmembrane 395 406 non-cytoplasmic 407 425 transmembrane 426 465 cytoplasmic
Input: >Pf1N1B4_5058 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_5058 LNTHKSPPDPTVLARAAAKVKRHVLPLFVVMFIVNYIDRVNIGFVRSHLETDLGIGAAAY GLGAGLFFIGYAIFEVPSNMLLQRYGARAWLTRIMFTWGAAAMAMAFVRGETSFYVLRFI LGAAEAGFFPGIIYYFTQWLPSTERGKAMAIFLSGSAIASVISGPLSGALLHVSGLSLHG WQWMFLIEGFASIVLCGFVWFWLQSHPREAKWLSAEERDALVSAIDLEQQAREAVQTVKP SMFKLLADRQVALFCFIYFSIALTIYGATFWLPSMIKKMGNLGDFQVGLFNSIPWIISIL AMYGFAAMASKWKYQQAWVAVTLVIAAFGMFMSTTGGPIFAFVAICFAAIGFKAASALFW PIPQGYLDARIAAAVIALINSIGNLGGFVAPTAFGFLEQTTGSIEGGLYGLAATSLVAAV VIFFARTAPRGDTRSSLTGKTVDATAAKNSVSHQALNTEPKGAAS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server